Filter by

Reset filter
December 18, 2025 Article

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

In-vivo CAR-T therapy delivers genetic instructions to immune cells inside the patient, aiming to reduce ex-vivo manufacturing constraints, shorten time...

Read more
December 2, 2025 Article

Inside China’s Early-Phase Trial Boom: Novotech’s China Managing Director Andy Liu Weighs In

In a recent PharmaBoardroom interview, Andy Liu, Novotech’s Managing Director for China, explains how regulatory reforms since 2015 and fa...

Read more
November 13, 2025 Article

Investor focus shifts to late-stage development in biotech, expert says

Investor sentiment in the biotech sector is shifting toward late-stage development, as funding increasingly favors companies with proven clinical d...

Read more
November 12, 2025 Article

The Evolving RNA Landscape: Strategy, Scale, and Speed

RNA therapeutics are moving fast....

Read more
November 3, 2025 Article

Advancing the Use of AI Tools in Hepatology Drug Development

AI is redefining the future of hepatology drug development....

Read more
September 19, 2025 Article

Ex-US Clinical Trials: Strategic Advantage for 2025

In a recent article, Novotech leaders Scott Schliebner, Vice President - Drug Development Consulting, and Renita Hite, Director Regulatory (Drug...

Read more
September 12, 2025 Article

Smarter Trials Start With Smarter Data Management

Sponsors today need faster decisions, cleaner insights, and real-time visibility across countries, vendors, and sites....

Read more
August 7, 2025 Article

Novotech Featured in Market Access Today for In-Vivo CAR-T Therapies Insights

Novotech’s latest white paper 2025 Global R...

Read more
July 29, 2025 Article

Adapting to Funding and Operational Hurdles in Today’s Clinical Trials Landscape

Discover how biotech leaders are responding to global clinical trial challenges. As clinical development faces mounting funding const...

Read more
July 25, 2025 Article

China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline

China is redefining clinical trial speed and innovation. Discover how Novotech helps biotech sponsors leverage what Andy Liu calls “China...

Read more
July 16, 2025 Article

Asia-Pacific Clinical Trials Market Growth & Insights

Asia-Pacific is emerging as a strategic hub for global clinical trials, with the market expected to grow at 7.3% CAGR...

Read more
July 14, 2025 Article

Rethinking Clinical Trials: Yooni Kim on Why an Ex-US Strategy Accelerates Success

Amid growing delays and rising costs in U.S. clinical trials, biotechs are looking for smarter ways to accelerate development. Yooni...

Read more
July 8, 2025 Article

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success

Discover how strong CRO-sponsor partnerships can drive clinical trial success through strategic collaboration, transparent communication, and shared performance goals. Learn...

Read more
June 30, 2025 Article

How a Tough Funding Climate is Reshaping US Clinical Trial Activity

Biotech sponsors are facing new pressures—and the effects are rippling through the clinical research landscape.In a recent feature by Clin...

Read more
May 28, 2025 Article

New weight loss drugs: Biotech’s mission to end obesity

Obesity now affects over 2.5 billion adults and nearly 400 million children and teens worldwide, making it a leading driver...

Read more
May 26, 2025 Article

Precision Medicine: Implementing The Right Test At The Right Time To Improve Clinical Outcomes

Access expert perspectives on the evolving precision medicine landscape in this exclusive roundtable report, developed in collab...

Read more
April 28, 2025 Article

Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific – BiopharmaTrend

According to a recent article by BiopharmaTrend (April 24, 2025), Novotech CRO has released a global market analysis identifying over...

Read more
April 25, 2025 Article

Novotech CEO Highlights Flexible Clinical Trial Solutions Amid Geopolitical and Trade Tensions

In a recent interview with Scrip, Novotech CEO Dr....

Read more
April 22, 2025 Article

Speed of China’s early clinical trials raises bar for Western biotechs

China’s rapid-fire approach to early-stage clinical trials is redefining global drug development standards....

Read more
April 1, 2025 Article

The Biggest Challenge in Running a Chronic Hepatitis B Trial is Often Patient Recruitment

Something that you wouldn’t really expect for a disease with over 250 million people infected worldwide. However, the areas where...

Read more
March 27, 2025 Article

Novotech Expands South Korean Presence with New Hospital Trial Site Deal

In a recent feature from Clinical Insider, Novotech announced a strategic partnership with Kyungpook National University Hospital (KNUH), expanding...

Read more
March 26, 2025 Article

Bladder Cancer: Challenges, Innovations, and Opportunities for Primary Care Physicians

In a recent article from Medical Economics, Sarah Anderson, Novotech’s Therapeutic Strategy Lead – Oncology, outlines the evolving landscape of...

Read more
February 19, 2025 Article

Navigating the Future of Clinical Trials: Expert Insights for 2025

Expert Outlook: Scott Schliebner on the Future of Clinical Trials in 2025As featured in Scrip | “Scrip Asks......

Read more
February 5, 2025 Article

Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons

Southeast Asia offers a unique opportunity for sponsors conducting clinical trials with vaccine candidates including faster recr...

Read more
December 19, 2024 Article

Navigating Clinical Trial Success: Key Takeaways for Korean Biotechs Expanding in Europe

Key Takeaways: Understanding the European Clinical Trials Regulation (CTR):...

Read more
December 4, 2024 Article

Biotech Clinical Trial Success: Key Lessons from Industry Leaders

The biotech industry is rapidly evolving, yet companies face significant challenges in executing clinical trials....

Read more
June 26, 2024 Article

South Korea and Australia on the rise as clinical research hubs

Novotech’s vice president highlighted the APAC region’s growing clinical presence, drawing attention to Australia and South Korea....

Read more
January 17, 2024 Article

Assessing the pros and cons of basing clinical trials in today’s European landscape

Access expert perspectives from a recent roundtable event during which panelists discussed the critical factors at play when comparing the...

Read more
December 14, 2023 Article

Q&A with Judith Ng-Cashin, CRO Novotech's chief medical officer, on 2023 and beyond

Last month, Judith Ng-Cashin became Novotech's first chief medical officer, with an eye toward expanding the Asia-Pacific contract research organiz...

Read more